Treatment of hepatitis C virus infection
WHO estimates that in 2015, 71 million people were living with chronic hepatitis C virus (HCV) infection worldwide, and 399 000 died from cirrhosis or hepatocellular carcinoma caused by HCV infection.
In 2013–2014, a new class of oral medicines called direct-acting antivirals revolutionized HCV treatment. With a cure rate of over 95%, direct-acting antivirals have fewer side effects than previous, less effective therapies, and patients can be fully cured with an 8–12 week course of the medicines.
Latest policy guidance
Updated recommendations on treatment of adolescents and children with chronic HCV...
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
This policy brief focuses on the new recommendations on treatment of adolescents and children aged 3 years or older with chronic hepatitis C virus (HCV)...
Publications
Accelerating access to hepatitis C diagnostics and treatment
WHO approved more hepatitis direct-acting antivirals (DAAs) for the treatment of infection with the hepatitis C virus (HCV) by 2020 which helped low-...
Access to hepatitis C testing and treatment for people who inject drugs and people in prisons — a global...
WHO estimates that 71 million people worldwide were chronically infected with hepatitis C virus (HCV) in 2017. Globally, 23% of new HCV infections and...
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
These guidelines aim to provide evidence-based recommendations on the care and treatment of persons diagnosed with chronic hepatitis C infection. They...
Progress report on access to hepatitis C treatment
Increased access to highly effective direct-acting antivirals (DAAs) for the treatment of infection with the hepatitis C virus (HCV) is revolutionizing...
This is the first-ever global report on treatment access to hepatitis C medicines. The report provides the information that countries and health authorities...